Can Tamoxifen Manage Breast Events Induced by Non-Steroidal Antiandrogens in Men with Advanced Prostate Cancer?

Many of us who are fighting advanced prostate cancer struggle with the perplexing side effects of non-steroidal antiandrogens (like Casodex). These side effects include gynecomastia (breast enlargement) and breast pain. In most cases as we use these drugs our breasts grow, become very sensitive and/or painful. In my case my breasts have grown to the [...]

Sharecare Honors Ten Prostate Cancer Influencers, Including Me!

Yesterday, I was given the honor of being named as one of the ten “influencers” in prostate cancer. The honor was extended by sharecare.org (twitter- Sharecare ?@SharecareNow ). Sharecare is active in many health issues, their prostate cancer expert’s page can be seen at: I am joined by some remarkable people; John McHugh, M.D. - [...]

No PSA Test Means More Men will be Diagnosed with A Terminal Illness, Advanced Prostate Cancer

Finally, we are getting a little common sense discussion about the role of PSA screening. Not to beat a dead horse, but as we all know the United Sates Preventive Task Force (USPTF) changed their rating of the PSA test from a D to a F. The result of this change is that many doctors, [...]

AUA 2012 – The Absence of Goal Setting in the Dialogue between Men with Advanced Prostate Cancer and their Doctors

What are our goals as advanced prostate cancer survivors and what are the goals of our oncologists? Often they are not the same! This misalignment between our expectations and those of our clinicians is common, but inexcusable. These issues become clear when we look at issues surrounding our quality of life. The treatments for advanced [...]

The Current Status of the Debate on Prostate Cancer Screening

All of us in the prostate cancer world know that the U.S. Preventive Services Task Force (USPTF) has announced its recommendation against routine PSA screening for men. There remains much debate and unhappiness in both the medical community (urologists and oncologists) as well as in the prostate cancer community itself. There remains a lot of [...]

Go to Top